<DOC>
	<DOCNO>NCT00235092</DOCNO>
	<brief_summary>The main objective study compare performance Cypher sirolimus-eluting Taxus paclitaxel-eluting stent system prospective , multi-center , randomized clinical study .</brief_summary>
	<brief_title>The REALITY Study - Head-to-Head Comparison Between Cypher Taxus</brief_title>
	<detailed_description>This prospective , randomize study conduct 90 center Europe , Latin-America Asia . A total 1335 patient enter study randomize 1:1 basis either sirolimus-eluting paclitaxel-eluting stent system . All patient repeat angiography eight month follow 24 month post-procedure .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>1 . Diagnosis angina pectoris define Canadian Cardiovascular Society Classification ( CCS I , II , III , IV ) OR unstable angina pectoris ( Braunwald Classification B &amp; C , IIIIII ) OR patient document silent ischemia ; 2 . Treatment two de novo native coronary artery lesion maximum two major coronary artery ; 3 . Ostial lesion ; 4 . Bifurcations ; 5 . Target vessel diameter lesion must &gt; =2.25mm &lt; =3.0mm diameter ( visual estimate ) ; 6 . One target lesion must least 15 mm length second lesion least 10 mm length upper limit either ; 7 . Target lesion stenosis lesion &gt; 50 % &lt; 100 % ( visual estimate ) . 1 . Patient experience Qwave nonQwave myocardial infarction document total CK &gt; 2 time normal within precede 72 hour CK CKMB enzymes remain normal time treatment ; 2 . Has unstable angina classify Braunwald A IIIIII ; 3 . Any lesion unprotected leave main coronary disease &gt; =50 % stenosis ; 4 . Angiographic evidence thrombus within target lesion ; 5 . Heavily calcified lesion and/or calcify lesion , successfully predilated ( applies lesion ) ; 6 . Documented leave ventricular ejection fraction &lt; =25 % ; 8 . Totally occluded vessel ( TIMI 0 level ) ( applies lesion ) ; 9 . Prior stent within 10mm target lesion ( applies lesion ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2007</verification_date>
</DOC>